3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Prostatic Neoplasms
2
Lymphoma
2
Sleep Initiation and Maintenance Disorders
1
Sedentary Behavior
1
Oligodendroglioma
1
Meningioma
1
Leukemia, Myeloid, Acute
1
Glioma
1
Glioblastoma
1
Fatigue
1
Breast Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
69
Bevacizumab
40
Radiotherapy
22
Magnetic Resonance Spectroscopy
20
Irinotecan
17
Specimen Handling
10
Carboplatin
10
Carmustine
9
X-Rays
7
Radiation
7
olaparib
6
Surgical Procedures, Operative
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Nivolumab
6
Everolimus
6
Cyclophosphamide
6
Biopsy
6
trametinib
5
Thalidomide
5
Cisplatin
5
pembrolizumab
4
palbociclib
4
fluorodopa F 18
4
erdafitinib
4
dabrafenib
4
Lomustine
4
Etoposide
4
Drug Therapy
4
Doxorubicin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Glioma
×
Cognitive Behavioral Therapy
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled